Federation des caisses Desjardins du Quebec’s Vanda Pharmaceuticals VNDA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.8K	Buy	1,925 +920	+92%	+$6.01K	﹤0.01%	2364
2026 Q1	$6.95K	Buy	+1,005	New	+$7.75K	﹤0.01%	2421
2020 Q2	–	Sell	-17,687	Closed	-$185K	–	2273
2020 Q1	$185K	Hold	17,687	–	–	﹤0.01%	882
2019 Q4	$290K	Buy	17,687 +4,000	+29%	+$60.5K	﹤0.01%	942
2019 Q3	$182K	Buy	13,687 +3,323	+32%	+$46.3K	﹤0.01%	1109
2019 Q2	$146K	Buy	+10,364	New	+$165K	﹤0.01%	1189

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's VNDA Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Vanda Pharmaceuticals (VNDA) stake by 92% in Q2 2026, buying an estimated $6.01K and bringing the position to 1,925 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

Federation des caisses Desjardins du Quebec first reported a position in VNDA in Q2 2019 and has held it in 6 quarters since. The position peaked at $290K in Q4 2019. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Federation des caisses Desjardins du Quebec held 1,925 shares of Vanda Pharmaceuticals worth $11.8K as of Q2 2026.
Federation des caisses Desjardins du Quebec bought 920 Vanda Pharmaceuticals shares in Q2 2026, an estimated $6.01K.
Vanda Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2364 holding.
Federation des caisses Desjardins du Quebec first reported a position in Vanda Pharmaceuticals in Q2 2019 and has held it in 6 quarters since.
Federation des caisses Desjardins du Quebec's Vanda Pharmaceuticals position peaked at $290K in Q4 2019.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.